Updated August 2026: In my recent research, I’ve been closely monitoring the latest breakthroughs in mTOR and AMPK signaling pathways, and 2025 has brought some exciting developments. Scientists have uncovered new evidence highlighting a dynamic crosstalk between these pathways under metabolic stress, suggesting that their interaction is more context-dependent than previously thought. Notably, recent studies…
Updated August 2026: I’ve been monitoring the latest breakthroughs in 2024-2025, and recent studies have solidified the role of mTOR as a key regulator of aging processes. Notably, new clinical trials are exploring targeted mTOR inhibitors to delay age-related decline, with early results showing promising improvements in cellular health and longevity markers. In my recent…
Updated July 2026: In my recent research, I’ve been monitoring the groundbreaking advancements in mTOR research, especially the emerging role of mTOR inhibitors in personalized medicine. The latest clinical trials from early 2025 reveal promising results in targeting age-related diseases and certain cancers, with new formulations showing increased efficacy and fewer side effects. Additionally, recent…